Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine solution protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, the company offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.
Huaren Pharmaceutical Dividend Announcement
• Huaren Pharmaceutical announced a annually dividend of ¥0.02 per ordinary share which will be made payable on 2024-07-10. Ex dividend date: 2024-07-10
• Huaren Pharmaceutical annual dividend for 2024 was ¥0.02
• Huaren Pharmaceutical annual dividend for 2023 was ¥0.02
• Huaren Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.51%
• Huaren Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 61.08%
• Huaren Pharmaceutical's dividend growth over the last five years (2018-2023) was 4.71% year
Huaren Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-10 | ¥0.02 | annually | 2024-07-10 |
2023-07-12 | ¥0.02 | annually | 2023-07-12 |
2022-06-17 | ¥0.02 | annually | 2022-06-17 |
2021-06-04 | ¥0.01 | annually | 2021-06-04 |
2020-05-19 | ¥0.01 | annually | 2020-05-19 |
2019-07-11 | ¥0.03 | annually | 2019-07-11 |
2018-05-22 | ¥0.02 | annually | 2018-05-22 |
2017-11-01 | ¥0.01 | annually | 2017-11-01 |
2017-05-31 | ¥0.01 | annually | 2017-05-31 |
2015-07-01 | ¥0.04 | annually | |
2014-05-07 | ¥0.13 | annually | |
2012-05-30 | ¥0.17 | annually |
Huaren Pharmaceutical Dividend per year
Huaren Pharmaceutical Dividend growth
Huaren Pharmaceutical Dividend Yield
Huaren Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.51%. Interested in purchasing Huaren Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Huaren Pharmaceutical Financial Ratios
Huaren Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Huaren Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Huaren Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Huaren Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Huaren Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Huaren Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Huaren Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Huaren Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Huaren Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Huaren Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Huaren Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Huaren Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.